Press release content from Business Wire. The AP news staff was not involved in its creation. Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing April 1, 2021 GMT SAN DIEGO--(BUSINESS WIRE)--Mar 31, 2021-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it is partnering with the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) on an innovative community health initiative called “Say Yes! COVID Test” in Pitt County, North Carolina, and coming soon to Chattanooga/Hamilton County, Tennessee. Quidel is providing two million QuickVue® At-Home OTC COVID-19 Tests to be distributed to approximately 160,000 residents free of charge across the two communities. The study is designed to determine if access to at-home rapid antigen tests three times a week for one month can significantly reduce virus spread in vulnerable communities.